ClinicalTrials.gg
Drug

Ketorolac Tromethamine clinical trials

Also written Toradol and SPRIX.

A product of Ketorolac; its studies count on that page too.

studies test it
95
open now
10
in phase 3
19
first study started
2000

How each study uses Ketorolac Tromethamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ketorolac Tromethamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Nov 1989 · TORADOL · NDA 019698 (FDA, Drugs@FDA)
European Union
28 Jul 2015 · Omidria · EMEA/H/C/003702 (EMA; as Ketorolac; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ketorolac Tromethamine
53
ketorolac
8
Intranasal Ketorolac Tromethamine
3
NTM-001 (Ketorolac Tromethamine IV Continuous Infusion)
2
Ketorolac Tromethamine 0.45%
2

Brand

Toradol
26
SPRIX
6
Acuvail
5
Acular
2
Dolac
1

Studies by the year they started

94 studies that test it; most in 2012 (8)

Studies that test Ketorolac Tromethamine, by start year
YearStudies
20001
20011
20021
20031
20041
20053
20063
20076
20082
20097
20102
20112
20128
20135
20145
20155
20164
20176
20185
20194
20202
20217
20225
20231
20242
20254
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
17
Phase 2
18
Phase 3
19
Phase 4
33
No phase
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 71

Egalet Ltd (13) · Azad University of Medical Sciences (4) · American Regent, Inc. (3) · Hamilton Health Sciences Corporation (2) · Cairo University (2) · Montefiore Medical Center (2) · EMS (2) · Antonios Likourezos (2)

Often tested with

Tested in the same studies.

Acetaminophen (8) · Lidocaine (6) · Gabapentin (5) · Bromfenac (4) · Bupivacaine (3) · Tramadol (3) · Nepafenac (3) · Methylprednisolone (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test Ketorolac Tromethamine, phase 3 first.

Studies

Open first, then newest update. How each study uses Ketorolac Tromethamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 95

See all 95 studies that test Ketorolac Tromethamine →

Given beside what is tested · 2 — Ketorolac Tromethamine is usual care or a partner of the new treatment
As the comparator · 10 — what is tested is compared with Ketorolac Tromethamine

Codes

What other systems call Ketorolac Tromethamine · ClinicalTrials.gg INT008780

  • MeSH (NLM) D020911Ketorolac TromethamineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 4EVE5946BQKETOROLAC TROMETHAMINEConfirmed FDA, NLM, Wikidata
  • RxNorm 28200Confirmed FDA, Wikidata
  • Wikidata Q27107089ketorolac tromethamineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61798Ketorolac TromethamineOne source FDA
  • DrugBank DBSALT001045One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.